Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study by Juan M. Cano-Calderón, Juan F. Zazueta-Pozos, Adán G. Gallardo-Rodríguez, Carlos Martínez-Murillo, Irma Olarte-Carrillo, Adolfo Martínez-Tovar, Christian O. Ramos-Peñafiel

Subjects: “…Multiple myeloma. Bortezomib. Thalidomide. Acute phase response. Survival.…”
Get full text

A Novel Green Synthesis of Thalidomide and Analogs by Ellis Benjamin, Yousef M. Hijji

“…Thalidomide and its derivatives are currently under investigation for their antiangiogenic, immunomodulative, and anticancer properties. …”
Get full text

Therapeutic Potential for Cytokine Antagonists: Thalidomide and Pentoxifylline in Hansen’s Disease by Theresa C Peterson

“…Recent evidence suggests that Hansen’s disease, which is characterized by reactional states, is associated with elevated serum levels of tumour necrosis factor-α (tnf-α) and interleukin-1β during these reactional states. Thalidomide, a drug used to treat reactional states in Hansen’s disease, has been reported to enhance degradation of tnf-α mrna. …”
Get full text

Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis

“…<p>This study was to evaluate the effects of thalidomide on expression of adhesion molecules in liver cirrhosis. …”
Get full text

Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis by Peng Lv, Shelley Chireyath Paul, Yanjv Xiao, Shiquan Liu, Hesheng Luo

“…This study was to evaluate the effects of thalidomide on expression of adhesion molecules in liver cirrhosis. …”
Get full text

Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl by Mackenzie L. Shindorf, Prabir K. Chaudhuri

“…Here, we present a 38-year-old man found to have an unresectable metastatic paraganglioma located in the Organ of Zuckerkandl who has been treated with single-agent thalidomide for over 15 years with minimal growth and stabilization of metastatic lesions. …”
Get full text

THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA by Kun Yang, Jian Xiao

“…Thalidomide is a therapeutic option for patients with β-­thalassemia by increasing fetal hemoglobin and thereby reducing the requirement for blood transfusions. …”
Get full text

Dramatic Reduction in Tumour Size in Hepatocellular Carcinoma Patients on Thalidomide Therapy by Denny Demeria, Iain Birchall, Vincent G Bain

Get full text

EFFECTS OF THALIDOMIDE ON ENDOTHELIAL ACTIVATION AND STRESS INDEX IN CHILDREN WITH Β-THALASSEMIA MAJOR by Kun Yang

Get full text

Multifocal Arterial Thrombosis during Thalidomide Therapy: Case Report and Review of the Literature by Monica Ferri, Gianluca Faggioli, Francesca Fratesi, Andrea Stella

“…Introduction. Thalidomide has been associated with both venous and arterial thrombotic events. …”
Get full text

Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis by Faisal Albaqami, Khawaja Waqas Ahmad, Fawad Ali Shah

Subjects: Get full text

Cutaneous pseudolymphoma: a case series of three patients by Yue Yao, Yue Yao, Yue Yao, Yijia He, Yijia He, Yijia He, Zhuochen Wu, Zhuochen Wu, Zhuochen Wu, Jinfang Zhang, Jinfang Zhang, Jinfang Zhang, Guoqiang Zhang, Guoqiang Zhang, Guoqiang Zhang

Subjects: Get full text

Protective Effect of Thalidomide on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis in Rats via the Inhibition of T Helper 17 Cells by Ying Xie, Dandan Li, Xiaoshuang Luan, Shuang Jin, Bo Yan, Feng Tian

“…To observe the effects of thalidomide on 2,4,6-trinitrobenzenesulfonic acid- (TNBS-) induced experimental colitis in rats and to explore the possible mechanism of thalidomide in the treatment of CD. …”
Get full text

Deep Venous Thrombosis in Patients with Erythema Nodosum Leprosum in the Use of Thalidomide and Systemic Corticosteroid in Reference Service in Belo Horizonte, Minas Gerais by Luiz Alberto Bomjardim Pôrto, Maria Aparecida de Faria Grossi, Edilamar Silva de Alecrim, Marcus Henrique de Souza Brito Xavier, Frederico Paiva e Silva, Amalia Sathler Pires, Fabianny Sanglard da Silva, Sandra Lyon

“…To report cases of ENL with DVT in the use of thalidomide/corticosteroid associated. Methodology. …”
Get full text

Protective Effects of Thalidomide on High-Glucose-Induced Podocyte Injury through In Vitro Modulation of Macrophage M1/M2 Differentiation by Hui Liao, Yuanping Li, Xilan Zhang, Xiaoyun Zhao, Dan Zheng, Dayue Shen, Rongshan Li

“…Our previous study on diabetic nephropathy rats indicated that thalidomide (Tha) has renoprotective properties. The present study explored the effects of Tha on mRNA and protein expressions of inducible nitric oxide synthase (iNOS), tumor necrosis factor- (TNF-) α, mannose receptor (CD206), and arginase- (Arg-) 1 in HG-activated macrophages. iNOS and TNF-α are established as markers of classically activated macrophage (M1). …”
Get full text

Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis by Yin-Che Wang, Cheng-Hsien Lin, Yu-Chen Su, Chieh-Lin Jerry Teng

Get full text

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma by Ka-Won Kang, Dae Sik Kim, Se Ryeon Lee, Mi Hwa Heo, Hyeon-Seok Eom, Jongheon Jung, Ji Hyun Lee, Sung-Hyun Kim, Youngil Koh, Chang-Ki Min, Seung Shin Lee, Sung-Nam Lim, Ho-Young Yhim, Myung-won Lee, Je-Jung Lee, Sung-Hoon Jung, Soo-Mee Bang, Kihyun Kim, the Korean Multiple Myeloma Working party [KMMWP]

Subjects: Get full text

Synthesis, <i>In Vitro</i> and <i>In Silico</i> Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents by Wael Shehta, Norah A. Alsaiari, Basant Farag, Marwa M. Abdel-Aziz, Shaker Youssif, Sherin M Elfeky, Samar El-Kalyoubi, Nermine A. Osman

Get full text

PYR-41 and Thalidomide Impair Dendritic Cell Cross-Presentation by Inhibiting Myddosome Formation and Attenuating the Endosomal Recruitments of p97 and Sec61 via NF-κB Inactivation by Xiang You, Dan Dan Xu, Di Zhang, Jie Chen, Feng Guang Gao

“…PYR-41 and thalidomide have therapeutic effects on inflammation-associated diseases with side effects such as tumorigenesis. …”
Get full text

Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy by Gianluca Cavallaro

Get full text